Author

Elliot Lawrence

Institution: University of Nebraska Medical Center

Observed institutions: Nebraska Medical Center, University of Nebraska Medical Center

ORCID: 0000-0002-8023-7838

Observed ORCID: 0000-0002-8023-7838

OpenAlex ID: A5089177130

Positive margins matter regardless of subsequent resection findings

2022 · Brendan Coutu, Evan Ryan, et al. · Oral Oncology · 25

Phase I/II study to evaluate consolidative hypofractionated radiation therapy for boosting the residual primary disease in combination with durvalumab after definitive chemoradiation therapy for stage III non-small cell lung cancer (NSCLC): study protocol for a prospective trial

2024 · Brendan Coutu, Elliot Lawrence, et al. · Journal of Thoracic Disease · 1

Post Autologous Stem Cell Transplant Consolidative Radiation Therapy for the Treatment of Relapsed/ Refractory Hodgkin Lymphoma

2026 · Joseph Carmicheal, Brendan Coutu, et al. · Graduate Medical Education Research Journal

Consolidative radiation in the management of relapsed/refractory Hodgkin lymphoma: a single institution study

2026 · Brendan Coutu, Joseph Carmicheal, et al. · Radiation Oncology

Works count: 4

Citation count: 26

H-index: 1

I10-index: 1